News for CAMX Stock

CHMP recommends approval of Oczyesa® for treatment of acromegaly in the EU Camurus announces positive Phase 3 results from the ACROINNOVA 2 study of octreotide SC depot (CAM2029) in acromegaly patients New publication shows effectiveness data for weekly and monthly buprenorphine injections in treating opioid dependence in individuals using fentanyl Camurus announces new Phase 3 data reinforcing long-term safety and efficacy of octreotide SC depot (CAM2029) in patients with acromegaly Camurus announces FDA approval of Brixadi™ for the treatment of moderate to severe opioid use disorder Cambiar Investors Launches Aggressive Value ETF